Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Predictive Oncology Inc POAI

Healthcare Medical Devices
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples... see more

Recent & Breaking News (NDAQ:POAI)

Predictive Oncology Announces CEO Retirement

GlobeNewswire September 16, 2022

Predictive Oncology Reports Second Quarter 2022 Financial Results

GlobeNewswire August 11, 2022

Traders News Source Senior Editor Mark Roberts Interviews J. Melville Engle, CEO and Chairman of the Board, Predictive Oncology

Accesswire August 9, 2022

Predictive Oncology Strengthens Business with Appointment of a Chief Scientific Officer and Consolidation and Expansion of its Research and Development Arm

GlobeNewswire July 26, 2022

Predictive Oncology Announces Closing of $7.2 Million Registered Direct Offerings

GlobeNewswire May 18, 2022

Predictive Oncology Announces $7.2 Million Registered Direct Offerings

GlobeNewswire May 16, 2022

Predictive Oncology Reports First Quarter Financial Results

GlobeNewswire May 12, 2022

Marketer with over 20 years of experience selected to head up marketing at Predictive Oncology

GlobeNewswire April 26, 2022

Predictive Oncology Reports Year End 2021 Financial Results and Provides Business Update

GlobeNewswire March 31, 2022

Predictive Oncology validates Discovery 21 proof-of-concept campaign

GlobeNewswire March 24, 2022

Predictive Oncology set to market AI drug discovery platform

GlobeNewswire January 27, 2022

POAI Reports Strong Results From Its AI Cancer Drug Evaluation  

GlobeNewswire January 13, 2022

Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021

GlobeNewswire December 27, 2021

Predictive Oncology - Year-end Shareholder Update!

GlobeNewswire December 21, 2021

Pamela Bush, Ph.D., MBA, Joins Predictive Oncology as SVP of Strategic Sales and Business Development

GlobeNewswire December 7, 2021

Predictive Oncology Acquires zPREDICTA, Inc.

GlobeNewswire December 1, 2021

Predictive Oncology Reports Third Quarter Financial Results

GlobeNewswire November 10, 2021

Predictive Oncology Launches Website Highlighting AI-Powered Cancer Research Advancements

GlobeNewswire October 19, 2021

Predictive Oncology Inc. Announces Newest Board Member

GlobeNewswire September 15, 2021

Predictive Oncology Announces Results of Charter Amendment Proposal at Special Meeting

GlobeNewswire August 18, 2021